Skip to main content
AUTL
NASDAQ Life Sciences

Autolus Secures $75M Senior Secured Notes, Up to $250M Total, with Premium Warrants, Addressing Going Concern

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Neutral
Importance info
9
Price
$1.52
Mkt Cap
$396.572M
52W Low
$1.175
52W High
$2.52
52W Position info
29% above low
Off High info
40% below high
Rel. Volume info
0.6× avg
Market data snapshot near publication time

AUTL sits 29% above its 52-week low of $1.175.

Summary

Autolus Therapeutics has secured a senior secured notes facility of $75 million immediately, with access to an additional $175 million, accompanied by warrants priced at a 25% premium, significantly improving its financial position after a recent going concern warning.

Updates

  1. · SEC 8-K — Preliminary Q2 AUCATZYL revenue ~$45M; 2026 guidance raised to $140–$150M; cash runway extended into Q2 2028.


Key Events · Financing and Capital Events · AUTL

  • New Debt Facility Secured

    Autolus Therapeutics entered into a senior secured notes facility for an aggregate principal amount of up to $250 million. An initial tranche of $75 million was issued on July 30, 2026, with three additional tranches totaling $175 million available upon meeting certain revenue milestones.

  • Warrants Issued at Premium

    The company issued warrants to purchase up to 3,500,000 American Depositary Shares (ADSs) with an exercise price of $1.9314 per ADS, representing a 25% premium to the 30-day volume-weighted average sale price. Additional warrants will be issued with future tranches.

  • Addresses Going Concern Risk

    This significant capital raise directly addresses the material uncertainty regarding the company's ability to continue as a going concern, which was disclosed in a previous 8-K filing on June 9, 2026.

  • Financial Covenants and Maturity

    The notes facility has a maturity date of July 30, 2031, and includes financial covenants requiring the company to maintain a minimum liquidity amount and minimum consolidated net revenue levels.


Analysis · AUTL · Life Sciences

This 8-K reports a critical financing event for Autolus Therapeutics, which recently disclosed a going concern warning. The company has secured a senior secured notes facility, providing an immediate $75 million and access to an additional $175 million, significantly bolstering its liquidity and extending its financial runway. While the facility adds debt and includes dilutive warrants, the warrants are priced at a 25% premium to the recent 30-day volume-weighted average price, indicating a degree of investor confidence in the company's future. The covenants for minimum liquidity and revenue will be important metrics to monitor. This transaction is a major step towards resolving the company's financial uncertainties.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 52.4% of the 208 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -1.91%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, AUTL was trading at $1.52 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $396.6M. The 52-week trading range was $1.18 to $2.52. This filing was assessed with neutral market sentiment and an importance score of 9 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

AUTL - Latest Insights

AUTL
Nov 10, 2026, 4:47 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $1.32
Real-time Price: $0.920 info
Change: -$0.400 (-30%) info
Market Cap: $241.651M info
AUTL
Nov 10, 2026, 7:00 AM EST
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $1.36
Real-time Price: $0.920 info
Change: -$0.4379 (-32%) info
Market Cap: $241.651M info
AUTL
Sep 09, 2026, 7:00 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $2.15
Real-time Price: $0.920 info
Change: -$1.23 (-57%) info
Market Cap: $241.651M info
AUTL
Aug 11, 2026, 4:13 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $2.31
Real-time Price: $0.920 info
Change: -$1.39 (-60%) info
Market Cap: $241.651M info
AUTL
Aug 11, 2026, 7:33 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $2.09
Real-time Price: $0.920 info
Change: -$1.17 (-56%) info
Market Cap: $241.651M info